FDA Expands Breakthrough Status for CymaBay (NASDAQ:CBAY) Seladelpar
Zolak/iStock via Getty Images CymaBay Therapeutics (NASDAQ:CBAY) said the FDA has expanded the breakthrough therapy designation for its drug candidate ...
Zolak/iStock via Getty Images CymaBay Therapeutics (NASDAQ:CBAY) said the FDA has expanded the breakthrough therapy designation for its drug candidate ...